ETO/AML t(8;21)-AML-M2

Description:

This test is useful in cases of Acute Myeloid Leukemia (AML) with a suspected AML/ETO translocation. The translocation of the AML1 gene (RUNX1) on chromosome 21 with the ETO gene (RUNX1T1) gene that encodes the CBFA2T1 protein on chromosome 8 forms a fusion protein. The t(8;21) abnormality predisposed to heterogeneous bone marrow malignancy, the Acute myeloid leukemia (AML). The test helps in detection of this translocation leading to AML-M2.

Technique:

Flourescent in Situ Hybridization

Specialities:

AML

Indications:

Hematological Maligancy

TAT:

3 days

Specimen Requirements:

Bone Marrow/Peripheral Blood in green top (Na-Heparin tube) 3-4 ml

Test Code:

2213

Quick Links

Maternal / Prenatal Screening

Pre-eclampsia Screening and Diagnosis

Prenatal Diagnosis

Non Invasive Prenatal Screening (NIPS)